Biovica share price explodes upon news and successfull offeringAdded this very promising swedish company to my watch list. Bit late to this party, but looking to buy if the usual sell the news shenanigans occur.
Biovica develops and commercializes blood-based biomarker assays to evaluate efficacy of cancer treatments.
Biovica’s assay DiviTum® measure cell p
−2.402SEK
−110.49 MSEK
3.38 MSEK
74.66 M
About BIOVICA INTERNATIONAL AB SER. B
Sector
Industry
CEO
Anders Rylander
Website
Headquarters
Uppsala
Employees (FY)
31
Founded
2008
ISIN
SE0008613731
FIGI
BBG00GBNTM29
Biovica International AB is engages in the development and commercialization of novel blood-based biomarker assays to improve the monitoring of modern cancer therapies. It offers DiviTum assay, which is intended to monitor and predict treatment response in cancer patients. The company was founded in 2009 and is headquartered in Uppsala, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BIOVIC_B is 1.676 SEK — it has decreased by 11.79% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BIOVICA INTERNATIONAL AB SER. B stocks are traded under the ticker BIOVIC_B.
BIOVICA INTERNATIONAL AB SER. B is going to release the next earnings report on Jul 3, 2024. Keep track of upcoming events with our Earnings Calendar.
BIOVIC_B stock is 26.67% volatile and has beta coefficient of 0.29. Check out the list of the most volatile stocks — is BIOVICA INTERNATIONAL AB SER. B there?
BIOVIC_B earnings for the last quarter are −0.30 SEK per share, whereas the estimation was −0.28 SEK resulting in a −6.37% surprise. The estimated earnings for the next quarter are −0.40 SEK per share. See more details about BIOVICA INTERNATIONAL AB SER. B earnings.
BIOVICA INTERNATIONAL AB SER. B revenue for the last quarter amounts to 3.00 M SEK despite the estimated figure of 4.00 M SEK. In the next quarter revenue is expected to reach 9.00 M SEK.
Yes, you can track BIOVICA INTERNATIONAL AB SER. B financials in yearly and quarterly reports right on TradingView.
BIOVIC_B stock has fallen by 32.83% compared to the previous week, the month change is a 33.75% fall, over the last year BIOVICA INTERNATIONAL AB SER. B has showed a 78.29% decrease.
BIOVIC_B net income for the last quarter is −27.34 M SEK, while the quarter before that showed −25.68 M SEK of net income which accounts for −6.46% change. Track more BIOVICA INTERNATIONAL AB SER. B financial stats to get the full picture.
Today BIOVICA INTERNATIONAL AB SER. B has the market capitalization of 159.71 M, it has decreased by 14.17% over the last week.
No, BIOVIC_B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BIOVIC_B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOVICA INTERNATIONAL AB SER. B stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 31.00 employees. See our rating of the largest employees — is BIOVICA INTERNATIONAL AB SER. B on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOVICA INTERNATIONAL AB SER. B technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOVICA INTERNATIONAL AB SER. B stock shows the sell signal. See more of BIOVICA INTERNATIONAL AB SER. B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on BIOVICA INTERNATIONAL AB SER. B future price: according to them, BIOVIC_B price has a max estimate of 20.00 SEK and a min estimate of 20.00 SEK. Read a more detailed BIOVICA INTERNATIONAL AB SER. B forecast: see what analysts think of BIOVICA INTERNATIONAL AB SER. B and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOVICA INTERNATIONAL AB SER. B EBITDA is −112.69 M SEK, and current EBITDA margin is −3.13 K%. See more stats in BIOVICA INTERNATIONAL AB SER. B financial statements.